RID: No data available
All atypicals may increase mortality in elderly patients by 1.7 times greater than placebo.
Max recommended dose 3 mg/day in moderate or severe renal impairment (CrCl < 50 mL/ min). Dose reduction (max 6 mg/day) is recommended with mild renal impairment (CrCl ≥50 mL/ min to <80 mL/ min)
No dose adjustment is required in patients with mild or moderate hepatic impairment.